GSK8814

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

GSK8814 is a potent and selective ATAD2 bromodomain chemical probe and inhibitor (IC50 = 0.059 μM), with a binding constant pKd = 8.1 and a pKi = 8.9 in BROMOscan. GSK8814 binds to ATAD2 and BRD4 BD1 with pIC50s of 7.3 and 4.6, respectively. GSK8814 shows 500-fold selectivity for ATAD2 over BRD4 BD1. GSK8814 can be researched for cancer associated with ATAD2 bromodomain.

For research use only. We do not sell to patients.

  • Purity: 99.80%
  • CAS No.: 1997369-78-4
  • Formula: C28H35F2N5O3
  • Molecular Weight:527.61
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) GSK8814

More

All Epigenetic Reader Domain Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00